跳至主要内容
临床试验/IRCT20190819044565N2
IRCT20190819044565N2招募中3 期

The evaluation of the effect of brewed chicory leaf consumption on liver steatosis, enzymes, metabolic syndrome components, oxidative stress markers, C-reactive protein in patients with non-alcoholic fatty liver disease

Oroumia University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Grade 2 and 3 non-alcoholic fatty liver disease through observation of steatosis in ultrasound
  • Older than 18 years
  • Interested in attending in study that filled out an informed consent form

排除标准

  • Mental, emotional, cognitive and mental disorders
  • Grade 1 non-alcoholic fatty liver disease
  • alcohol consumption
  • Hepatitis B, Hepatitis C, Autoimmune Hepatitis, Liver Cancer, Cholestatic Liver Disease
  • Rheumatoid arthritis and other acute inflammatory diseases
  • Taking non-steroidal anti-inflammatory drugs, cholesterol-lowering drugs to control blood pressure such as statins, phenytoin, karmabazepine and barbiturates such as phenobarbital
  • Alpha-1 antitrypsin deficiency
  • Pancreatitis
  • Heart failure
  • Bone diseases
  • Coeliac disease
  • Supplement of Vitamin, Antioxidant, Fiber and Omega 3
  • Do not regularly use of brewed chicory leaf during the study
  • Use of anticoagulants
  • Hepatotoxic drugs
  • Hereditary hemochromatosis
  • Wilson's disease
  • Pregnant women
  • Lactating women
  • Use of contraceptives drugs
  • liver transplant
  • kidney diseases
  • Changes in the level of physical activity during the study
  • Diabetes Mellitus
  • Hypothyroidism

研究者

发起方
Oroumia University of Medical Sciences

相似试验